When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RVNC - Why Revance Therapeutics Stock Is Jumping 13.1% Today
Revance Therapeutics Inc.
After the company announced an exclusive U.S. licensing deal to market multiple fillers used in cosmetic procedures, Revance Therapeutics shares (NASDAQ: RVNC) were up 13.1% at 12:30 p.m. EST on Friday.
Investors were hoping Revance Therapeutics would make the leap from clinical-stage to commercial-stage biotech stock this year pending Food and Drug Administration approval of DAXI, a long-lasting formulation of a neurotoxin designed to compete against Allergan's (NYSE: AGN) Botox.